Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Benbrook, Doris
Item TypeName
Concept Drug Evaluation, Preclinical
Concept Drug Screening Assays, Antitumor
Academic Article High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
Academic Article Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline).
Academic Article Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Academic Article Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma.
Academic Article Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.
Academic Article Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.
Academic Article Synthesis and evaluation of second generation Flex-Het scaffolds against the human ovarian cancer A2780 cell line.
Academic Article Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
Academic Article Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer.
Academic Article Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents.
Search Criteria
  • Drug Evaluation Preclinical